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Summary
Introduction:  The  role  of  ﬁne-needle  aspiration  cytology  (FNAC)  in  the  management  of  parotid
tumours is  still  the  subject  of  controversy.  The  purpose  of  this  study  was  to  determine  the
diagnostic  value  of  FNAC  in  our  institution  in  order  to  deﬁne  its  place  in  the  diagnostic  strategy.
Patients and  methods:  This  retrospective  study  was  based  on  249  patients  who  had  under-
gone preoperative  FNAC  before  being  operated  in  our  institution  between  2001  and  2008.  All
examinations  were  performed  and  interpreted  by  the  same  experienced  pathologist.
Results: Among  the  249  patients  included  in  this  study,  187  (75%)  had  a  benign  tumour  and  62
(25%) had  a  malignant  tumour.  No  complications  of  FNAC  were  observed.  Cytological  ﬁndings
were non-contributory  in  47  patients  (18%).  The  sensitivity  of  FNAC  for  the  diagnosis  of  malig-
nancy was  80%  with  a  speciﬁcity  of  89.5%.  Among  the  11  false-negative  results,  lymphomas  and
low-grade  mucoepidermoid  carcinomas  were  the  most  common  histological  types.  Among  the  16
false-positive  results,  Warthin’s  tumours,  pleomorphic  adenomas  and  lymphoepithelial  lesions
were the  most  common  histological  types.  Accurate  histological  classiﬁcation  of  the  tumour
was reported  in  79.5%  of  cases  (86%  for  benign  tumours  and  44%  for  malignant  tumours).
Conclusion:  FNAC  is  a  reliable  examination  providing  important  information  to  the  surgeon  in
the preoperative  diagnostic  assessment.
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ntroduction
ine-needle  aspiration  cytology  (FNAC)  is  a  well  tolerated,
elatively  painless,  easy  to  perform,  and  inexpensive  exam-
nation  with  few  contraindications.  Some  authors  consider
NAC  to  be  an  essential  element  of  the  diagnosis  and  treat-
ent  decision  (particularly  certain  English-speaking  teams
ho  do  not  systematically  perform  frozen  section  biopsy
hen  preoperative  FNAC  is  diagnosed),  while  others  con-
ider  that  this  technique  is  not  sufﬁciently  accurate.  FNAC
as  been  used  for  the  diagnosis  of  parotid  disease  since  the
980s  and  there  is  consequently  an  abundant  literature  on
his  subject  with  very  variable  results  from  one  team  to
nother  (Table  1)  [1—16].
Although  FNAC  is  now  part  of  routine  clinical  practice  for
he  evaluation  of  thyroid  tumours  [17]  and  cervical  lymph
odes,  no  consensus  has  been  reached  concerning  the  role
f  this  examination  in  the  management  of  parotid  disease,
s  some  authors  consider  that  it  has  a  low  sensitivity  for
alignant  tumours  [2,18—20].
The  purpose  of  this  study  was  to  determine  the  diag-
ostic  value  of  FNAC  in  our  institution  in  order  to
eﬁne  its  place  and  its  advantages  in  the  diagnostic
trategy.
atients and methods
 retrospective  study  was  conducted  on  249  patients  who
ad  undergone  preoperative  FNAC  before  being  operated
n  our  institution  between  2001  and  2008.  All  examinations
ere  performed  and  interpreted  by  the  same  experienced
athologist.
Data  were  obtained  from  pathology  reports.  FNAC  results
ere  compared  to  the  results  of  ﬁnal  histological  examina-
ion  of  the  operative  specimen.
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Table  1  Summary  of  studies  on  the  ﬁne-needle  aspiration  cytolog
disease.
n  Se  (%)
Orell  1995  [1]  325  85.5  
Al-Khafaj 1998  [2]  154  82  
Stewart 2000  [3]  341  92  
Zbaren 2001  [4]  228  64  
Postman 2004  [5]  388  88  
Cohen 2004  [6]  
Bajaj 2005  [7] 69  84  
Seethala 2005  [8] 220 86  
Aversa 2006  [9] 310 83
Uguz 2007  [10]  29  54  
Herrera  2007  [11]  46  54  
Lim 2007  [12]  91  80  
Lin 2007  [13]  279  63  
Carillo 2009  [14]  135  92  
Jafari 2009  [15]  110  67  
Schmidt 2011  [16]  (Meta-analysis)  6169  80  
Present study  202  80  
Se: sensitivity; Sp: speciﬁcity; PPV: positive predictive value.N.  Fakhry  et  al.
ine-needle  aspiration  cytology  technique
 25  Gauge  needle  was  introduced  into  the  mass  and  a
otation  movement  associated  with  to  and  fro  vertical  move-
ents  were  applied  to  the  needle.  The  histological  material
as  collected  by  capillarity  without  aspiration.  A  syringe
ontaining  5  mL  of  air  was  then  attached  to  the  needle  and
he  collected  material  was  expelled  onto  three  glass  slides,
y  placing  the  tip  of  the  syringe  on  the  slide.  The  material
as  then  smeared  and  dried  in  air  before  being  sent  to  the
ytology  laboratory.  Three  aspirations  were  performed  for
ach  tumour  in  order  to  optimise  cytological  examination
nd  to  reduce  the  number  of  non-contributory  slides  due  to
nsufﬁcient  material.
nalysis  of  the  results
hree  types  of  histological  results  were  provided  by  the
ytology  laboratory:
 benign  aspiration  cytology;
 suspicious  or  malignant  aspiration  cytology;
 non-contributory  aspiration  cytology  (indeterminate).
The  performances  of  FNAC:  sensitivity  (Se),  speciﬁcity
Sp),  negative  predictive  value  (NPV),  positive  predictive
alue  (PPV),  likelihood  ratios  (LR)  and  global  efﬁcacy  were
nalysed  by  SPSS® version  15.0  statistical  software  (SPSS,
hicago,  IL).
esultsmong  the  249  patients  included  in  this  study,  187  (75%)  pre-
ented  a  benign  tumour  and  62  (25%)  presented  a  malignant
umour.  No  complication  of  FNAC  was  observed.  The  FNAC
esults  are  summarized  in  Table  2.
y  of  the  parotid  gland  for  differentiation  of  benign/malignant
 Sp  (%)  Accuracy  (%)  PPV  (%)
99.5  98.5
86  84
100  98
95  86  83
99  96
84
96  94
92  90
100  97
100
90  70
100
97  81
98
96  80
97  90
89.5  86.5  73
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Table  2  Results  of  ﬁne-needle  aspiration  cytology  compared  to  ﬁnal  histology.
Benign  lesion  in  ﬁnal  histology  Malignant  lesion  in  ﬁnal  histology  Total
Benign  cytology  132  (true  positives)  11  (false-negative)  143
Suspicious-malignant  cytology  16  (false-positive)  43  (true  negatives)  59
Indeterminate  cytology  39  8  47
Total 187  
Table  3  Results  of  the  ﬁne-needle  aspiration  cytology  for
the diagnosis  of  malignancy.
[95%CI]
Se  79.63%  [65.06—86.8]
Sp 89.19%  [84.55—94.01]
PPV 72.88%  [61.02—83.35]
NPV 92.31%  [86.62—95.4]
PLR 7.99  [4.85—13.15]
NLR 0.25  [0.07—0.20]
Efﬁcacy  86.623%  [81.77—90.92]
Se: sensitivity; Sp: speciﬁcity; PPV: positive predictive value;
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wNPV: negative predictive value; PLR: positive likelihood ratio;
NLR: negative likelihood ratio.
FNAC  was  non-contributory  in  47  patients  (18%  of  cases).
These  non-contributory  cases  were  excluded  from  the  sta-
tistical  analysis,  as  FNAC  has  no  informative  value  in  these
situations.
Among  the  202  FNAC  samples  analysed,  a  correct  diag-
nosis  was  obtained  in  87%  of  cases,  a  false-negative  result
was  obtained  in  11  cases  (7.7%)  and  a  false-positive  result
was  obtained  in  16  cases  (27%).  The  calculated  sensitivity  for
the  diagnosis  of  malignancy  was  79.63%  with  a  speciﬁcity  of
89.19%.  The  positive  likelihood  ratio  (PLR)  was  7.99  and  the
negative  likelihood  ratio  (NLR)  was  0.25  (Table  3).
Among  the  11  false-negative  results  (Table  4),  lym-
phomas  and  low-grade  mucoepidermoid  carcinomas  were
the  most  common  histological  types  (nine  out  of  11  cases,
81.8%).  Among  the  16  false-positive  results  (Table  5),
Warthin’s  tumours,  pleomorphic  adenomas  and  lymphoep-
ithelial  lesions  were  the  most  common  histological  types.
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Table  4  Summary  of  false-negative  ﬁne-needle  aspiration  cytolo
Cytology  Cytological  diagnosis  
Benign  Mixed  benign  tumour  
Benign Mixed  benign  tumour  
Benign Lymphoepithelial  cyst  
Benign Indeterminate  
Benign Indeterminate  
Benign Warthin’s  tumour  
Benign Warthin’s  tumour  
Benign Warthin’s  tumour  
Benign Warthin’s  tumour  
Benign Warthin’s  tumour  
Benign Indeterminate  62  249
Histological  typing  of  the  tumour  was  able  to  be  per-
ormed  on  161  (79.5%)  of  the  202  contributive  FNAC
pecimens  of  this  series.  The  accuracy  of  histological  typ-
ng  was  86%  (106/123)  for  benign  tumours  and  44%  (17/38)
or  malignant  tumours.
iscussion
erformances  of  ﬁne-needle  aspiration  cytology
NAC  was  able  to  correctly  classify  parotid  tumours  in  87%
f  cases.  A  recent  review  of  the  literature  (Table  1)  reported
 sensitivity  ranging  from  54  to  92%  depending  on  the
eries  and  a  speciﬁcity  ranging  from  86  to  100%  [1—16]. A
eta-analysis  conducted  in  2011  also  demonstrated  an  esti-
ated  global  sensitivity  of  80%  and  an  estimated  speciﬁcity
f  97%  [16]. This  low  sensitivity  can  be  explained  by  the
igh  false-negative  rate  for  the  diagnosis  of  malignancy,  as
umours  were  falsely  classiﬁed  as  benign  in  8  to  46%  of  cases
epending  on  the  series.  In  the  present  study,  the  sensitivity
nd  speciﬁcity  were  80%  and  89%,  respectively,  in  line  with
he  data  of  the  literature.
The  rate  of  non-contributory  FNAC  is  one  of  the  major
rawbacks  of  this  diagnostic  technique,  as  it  ranges  from
 to  34%  depending  on  the  series  [3,4,21,22]. In  the  meta-
nalysis  by  Schmidt,  this  non-contributory  FNAC  rate  was
stimated  to  be  8.6%  [16]. In  the  present  study,  this  rate
as  relatively  high  at  18%,  but  in  line  with  the  litera-
ure.  This  high  rate  could  be  explained  by  the  fact  that  all
spiration  cytologies  in  this  series  were  performed  without
ltrasound  guidance,  which  could  result  in  a lower  diagnos-
ic  yield  for  cystic  tumours  and/or  tumours  situated  deep  in
gy  results  (n  =  11).
Final  histological  diagnosis
Low-grade  mucoepidermoid  carcinoma
Acinar  cell  carcinoma
Follicular  B-cell  lymphoma
Follicular  B-cell  lymphoma
Hodgkin’s  lymphoma
Low-grade  mucoepidermoid  carcinoma
Acinar  cell  carcinoma
Non-Hodgkin’s  malignant  lymphoma
Hodgkin’s  Lymphoma
Low-grade  mucoepidermoid  carcinoma
Low-grade  mucoepidermoid  carcinoma
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Table  5  Summary  of  false-positive  false-negative  ﬁne-needle  aspiration  cytology  results  (n  =  16).
Cytology  Cytological  diagnosis  Final  histological  diagnosis
Suspicious Malignant  mixed  tumour  Mixed  benign  tumour
Suspicious Indeterminate  Warthin’s  tumour
Suspicious Indeterminate  Warthin’s  tumour
Suspicious Indeterminate  Warthin’s  tumour
Suspicious Indeterminate Warthin’s  tumour
Suspicious Indeterminate Lymphoepithelial  cyst
Suspicious Indeterminate Lymphoepithelial  cyst
Suspicious Indeterminate  Obstructive  parotiditis
Malignant Malignant  mixed  tumour  Mixed  benign  tumour
Malignant Malignant  mixed  tumour  Mixed  benign  tumour
Malignant Malignant  mixed  tumour  Mixed  benign  tumour
Malignant Malignant  mixed  tumour  Warthin’s  tumour
Malignant Acinar  cell  carcinoma  Oncocytoma
Malignant Adenocarcinoma  Warthin’s  tumour
Malignant Indeterminate  Lymphoepithelial  cyst
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cMalignant Indeterminate  
he  parotid  parenchyma.  Bajaj  in  2005  and  Pratap  in  2009
howed  that  the  sensitivity  of  FNAC  was  increased  by  20%,
rom  to  65%  to  85%,  with  the  use  of  ultrasound  guidance
7,23].  Our  clinical  practice  has  been  modiﬁed  since  this
eries,  as  we  now  increasingly  tend  to  perform  ultrasound-
uided  FNAC.
No published  study  has  reported  a  sensitivity  of  FNAC
igher  than  92%.  There  is  therefore  a  relatively  high  risk  of
alse-negative  results  for  malignant  tumours  and  FNAC  can
herefore  never  formally  exclude  a  malignancy  and  there-
ore  cannot  reliably  reassure  the  surgeon  and  the  patient.
n  the  present  series,  18%  of  malignant  tumours  were  diag-
osed  as  benign  lesions  on  FNAC.
The  results  for  histological  typing  of  tumours  by  FNAC
ange  from  29  to  84%  depending  on  the  series  [2,4,20].
n  the  present  series,  among  the  161  cases  in  which
istological  typing  was  possible,  this  typing  was  accurate
n  86%  of  benign  tumours  and  44%  of  malignant  tumours.
istological  typing  of  primary  parotid  tumours  is  a  difﬁcult
xercise  and  our  results  are  comparable  to  those  published
n  the  literature.  These  results  can  be  explained  by  the  fact
hat  primary  malignant  tumours  of  the  parotid  are  much
arer  than  benign  tumours  and,  according  to  the  WHO  2005
lassiﬁcation  of  parotid  tumours,  there  are  more  than  25
ifferent  types  of  malignant  tumours  while  only  nine  types
f  benign  tumour  have  been  described,  predominantly  com-
osed  of  pleomorphic  adenomas  and  Warthin’s  tumours,
hich  makes  typing  of  benign  tumours  less  complex  than
hat  of  malignant  tumours.
alue  of  ﬁne-needle  aspiration  cytology  in  the
perative decision
he  value  of  FNAC  in  the  management  of  parotid
umours  remains  controversial.  The  majority  of  surgeons
o  not  plan  their  surgical  procedure  as  a  function  of
he  FNAC  results,  but  propose  exploratory  parotidectomy
ith  frozen  section  biopsy  and  modify  the  procedure
m
u
h
mMixed  benign  tumour
complementary  lymph  node  dissection)  according  to  the
perating  ﬁndings.
In  a  recent  study,  Lin  et  al.  demonstrated  that  preopera-
ive  knowledge  of  the  malignant  nature  of  a  parotid  tumour
odiﬁed  the  postoperative  course  [13]. When  the  surgeon
perates  with  the  intention  to  treat  a  malignant  tumour,  the
umber  of  concomitant  lymph  node  dissections  and  the  num-
er  of  negative  margins  on  histological  examination  of  the
perative  specimen  are  signiﬁcantly  increased.  According
o  these  authors,  preoperative  knowledge  of  the  malignant
ature  of  the  tumour  based  on  FNAC  improves  the  success  of
nitial  surgical  management  and  therefore  has  an  impact  on
ong-term  survival.  However,  it  should  be  noted  that  these
uthors  did  not  systematically  perform  frozen  section  biopsy
nd  that  their  approach  was  therefore  mainly  guided  by
NAC.
In  contrast,  O’Brien  considered  that  FNAC  should  only
e  recommended  when  the  cytology  results  would  be  likely
o  modify  management:  patients  in  poor  general  health,  in
hom  a  benign  diagnosis  on  FNAC  would  justify  conservative
anagement,  doubt  about  the  intraparotid  site  of  the  mass,
valuation  of  a  parapharyngeal  mass,  for  which  a  diagno-
is  of  malignancy  would  modify  the  surgical  incision,  when
he  swelling  appears  to  be  clinically  malignant  and  when
erve  sacriﬁce  appears  to  be  necessary,  or  when  a  metas-
asis  of  a  skin  cancer  is  suspected  and  concomitant  lymph
ode  dissection  is  required  [24].
The  meta-analysis  conducted  by  Schmidt  in  2011  and
ased  on  64  studies  and  more  than  6000  patients  demon-
trated  excellent  performances  of  FNAC  [16]. However,  due
o  the  marked  heterogeneity  of  recruitment,  methodologies
nd  results  between  the  various  studies,  the  authors  were
nable  to  reach  any  clear  conclusions  or  deﬁne  a  consensus
oncerning  the  approach  to  a  parotid  mass.
FNAC  alone  obviously  cannot  be  used  to  guide  surgical
anagement  and  imaging,  especially  MRI,  comprising  the
se  of  new  sequence  (diffusion-weighted  sequences),  now
as  a  very  important  place  in  the  management  of  parotid
asses  in  combination  with  FNAC  [25].
id  m
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Conclusion
Parotid  tumours  raise  diagnostic  problems  due  to  their  histo-
logical  diversity,  while  the  histological  nature  of  the  tumour
determines  planning  of  the  surgical  procedure  and  its
resulting  consequences  and  complications.  As  the  complica-
tion  rate  logically  increases  with  the  degree  of  invasiveness
of  the  surgical  procedure,  it  is  important  to  be  able  to
characterize  the  tumour  preoperatively  in  order  to  correctly
inform  the  patient  about  the  type  of  surgery  that  will  be
performed,  the  need  for  lymph  node  dissection  and  the
possibility  of  nerve  sacriﬁce.
FNAC  is  a  reliable  examination  that  provides  valuable
information  for  the  preoperative  diagnostic  work-up  and
alerts  the  surgeon  to  the  possible  presence  of  malignancy.
The  preoperative  information  provided  by  FNAC  in  the
case  of  a  malignant  result  allows:
•  staging;
•  deﬁnition  of  a  surgical  plan  in  terms  of  resection  margins,
the  need  for  lymph  node  dissection,  the  degree  of  urgency
of  treatment;
•  the  surgeon  to  give  more  appropriate  information  to  the
patient  about  the  surgical  plan  and  the  risk  of  postopera-
tive  facial  palsy.
Finally,  in  view  of  the  considerable  false-negative  rate,
FNAC  cannot  formally  exclude  malignancy  and  therefore
cannot  reliably  reassure  the  surgeon  and  the  patient.  Apart
from  a  few  selected  cases  (patients  in  poor  general  health,
for  example),  histological  examination  after  parotidectomy
is  always  necessary.
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